Some links on DirJournal are affiliate links. We only recommend verified businesses that clear our 12-point editorial audit standard.
Independent. Human-Curated. Established 2007.
Services combining genomic sequencing, biomarker testing and AI analysis to personalize health interventions.
Precision Medicine & Genomic Data Analysis currently lists 8 entities pending editorial audit.
Verified status arrives after a 12 point audit covering entity ownership, citation consistency across answer engines, schema validity, and operating history.
Ranking weights editorial tier and entity health score across the full listed set. No listings here carry the verification badge yet — they appear in order of editorial signal. Last updated .
San Diego, United StatesIllumina is the world leader in next-generation sequencing technology, providing platforms and services for whole genome sequencing and clinical precision medicine applications globally.
Authority Score
Redwood City, United StatesHealth 54/100Guardant Health develops liquid biopsy tests using cell-free DNA analysis for early cancer detection, therapy selection and treatment monitoring with minimally invasive blood draws.
Chicago, United StatesHealth 54/100Tempus AI applies artificial intelligence to genomic and clinical data to advance precision medicine, offering molecular profiling and real-world evidence tools for oncology care.
Cambridge, United StatesHealth 54/100Foundation Medicine provides comprehensive genomic profiling for cancer patients, delivering actionable molecular insights to guide targeted therapy selection and clinical trial matching.
Cambridge, United StatesHealth 54/100SOPHiA GENETICS provides a cloud-based AI platform enabling hospitals and labs to standardize genomic data analysis for oncology, rare disease and pharmacogenomics applications.
Oxford · United Kingdom
Genomics plc is a precision medicine company using genomic data and machine learning to calculate disease risk scores, partnering with health systems and biopharma to personalize preventive care.
Invitae is a medical genetics company offering comprehensive genetic testing across hereditary cancer, rare disease, reproductive health and pharmacogenomics to inform clinical decision-making.
Cambridge · United States
SOPHiA GENETICS provides a cloud-based AI platform enabling hospitals and labs to standardize genomic data analysis for oncology, rare disease and pharmacogenomics applications.
Cambridge · United States
Foundation Medicine provides comprehensive genomic profiling for cancer patients, delivering actionable molecular insights to guide targeted therapy selection and clinical trial matching.
Illumina is the world leader in next-generation sequencing technology, providing platforms and services for whole genome sequencing and clinical precision medicine applications globally.
Tempus AI applies artificial intelligence to genomic and clinical data to advance precision medicine, offering molecular profiling and real-world evidence tools for oncology care.
Redwood City · United States
Guardant Health develops liquid biopsy tests using cell-free DNA analysis for early cancer detection, therapy selection and treatment monitoring with minimally invasive blood draws.
Burlingame · United States
Color Health delivers population-scale genomic medicine programs, providing hereditary cancer and cardiac risk screening through employer and health system partnerships across the United States.
Join 8 listed Precision Medicine & Genomic Data Analysis providers. One payment, lifetime authority.
Secure Your $249.95 Permanent ListingList Your Business
Join 8 listed Precision Medicine & Genomic Data Analysis providers